Cargando…
Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System
BACKGROUND: Prostate cancer (PCa) is the most common malignant tumor in males and conventional imaging does not provide accurate primary staging. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) presents superior performance and strongly affects therapeutic choice. OBJECT...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062252/ https://www.ncbi.nlm.nih.gov/pubmed/36995451 http://dx.doi.org/10.1245/s10434-023-13365-y |
_version_ | 1785017451283480576 |
---|---|
author | da Silva, Anna Carolina Borges de Toledo, Luís Gustavo Morato de Carvalho Fernandes, Roni Ziroldo, Alan Rechamberg Sawczyn, Guilherme Vinícius Alarcon, Shirlene Tettmann Lewin, Fábio |
author_facet | da Silva, Anna Carolina Borges de Toledo, Luís Gustavo Morato de Carvalho Fernandes, Roni Ziroldo, Alan Rechamberg Sawczyn, Guilherme Vinícius Alarcon, Shirlene Tettmann Lewin, Fábio |
author_sort | da Silva, Anna Carolina Borges |
collection | PubMed |
description | BACKGROUND: Prostate cancer (PCa) is the most common malignant tumor in males and conventional imaging does not provide accurate primary staging. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) presents superior performance and strongly affects therapeutic choice. OBJECTIVE: The aim of this study was to evaluate the impact of PSMA PET, compared with conventional imaging methods, on the therapeutic approach in primary staging scenarios in patients with PCa treated at the Brazilian National Public Health System. METHODS: Overall, 35 patients diagnosed with PCa were evaluated using PSMA after conventional staging imaging with multiparametric magnetic resonance (MMR) and/or total abdominal computed tomography (CT) scan and bone scintigraphy (BS). The PCa extension identified by PET was compared with conventional imaging; staging changes and the management impact were then determined. PET comparison with conventional imaging, staging, and decision-making changes was analyzed using descriptive statistics. RESULTS: PET revealed local disease (LD) in 15 (42.9%) patients, seminal vesicle invasion (SVI) in 5 (14.3%) patients, pelvic nodal impairment (PNI) in 7 (20%) patients, pelvic and distant nodes in 3 (8.6%) patients, pelvic nodes and bone metastasis in 4 (11.4%) patients, and pelvic and distant nodes and bone metastasis in 1 (2.8%) patient. Staging changes were observed in 60% of patients, with downstaging predominance (76.2%). Volume increase was identified in 11 (31.4%) patients (only 4 related to upstaging, 36.4%). The board changed management decisions for 60% of the patients. The main limitations of this study were the sample size and its retrospective nature. CONCLUSIONS: PSMA findings changed the management decisions in more than half of the patients, which made the majority eligible for locoregional treatment and avoided unnecessary procedures in the systemic disease scenario. |
format | Online Article Text |
id | pubmed-10062252 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-100622522023-03-31 Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System da Silva, Anna Carolina Borges de Toledo, Luís Gustavo Morato de Carvalho Fernandes, Roni Ziroldo, Alan Rechamberg Sawczyn, Guilherme Vinícius Alarcon, Shirlene Tettmann Lewin, Fábio Ann Surg Oncol Urologic Oncology BACKGROUND: Prostate cancer (PCa) is the most common malignant tumor in males and conventional imaging does not provide accurate primary staging. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) presents superior performance and strongly affects therapeutic choice. OBJECTIVE: The aim of this study was to evaluate the impact of PSMA PET, compared with conventional imaging methods, on the therapeutic approach in primary staging scenarios in patients with PCa treated at the Brazilian National Public Health System. METHODS: Overall, 35 patients diagnosed with PCa were evaluated using PSMA after conventional staging imaging with multiparametric magnetic resonance (MMR) and/or total abdominal computed tomography (CT) scan and bone scintigraphy (BS). The PCa extension identified by PET was compared with conventional imaging; staging changes and the management impact were then determined. PET comparison with conventional imaging, staging, and decision-making changes was analyzed using descriptive statistics. RESULTS: PET revealed local disease (LD) in 15 (42.9%) patients, seminal vesicle invasion (SVI) in 5 (14.3%) patients, pelvic nodal impairment (PNI) in 7 (20%) patients, pelvic and distant nodes in 3 (8.6%) patients, pelvic nodes and bone metastasis in 4 (11.4%) patients, and pelvic and distant nodes and bone metastasis in 1 (2.8%) patient. Staging changes were observed in 60% of patients, with downstaging predominance (76.2%). Volume increase was identified in 11 (31.4%) patients (only 4 related to upstaging, 36.4%). The board changed management decisions for 60% of the patients. The main limitations of this study were the sample size and its retrospective nature. CONCLUSIONS: PSMA findings changed the management decisions in more than half of the patients, which made the majority eligible for locoregional treatment and avoided unnecessary procedures in the systemic disease scenario. Springer International Publishing 2023-03-30 2023 /pmc/articles/PMC10062252/ /pubmed/36995451 http://dx.doi.org/10.1245/s10434-023-13365-y Text en © Society of Surgical Oncology 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Urologic Oncology da Silva, Anna Carolina Borges de Toledo, Luís Gustavo Morato de Carvalho Fernandes, Roni Ziroldo, Alan Rechamberg Sawczyn, Guilherme Vinícius Alarcon, Shirlene Tettmann Lewin, Fábio Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System |
title | Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System |
title_full | Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System |
title_fullStr | Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System |
title_full_unstemmed | Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System |
title_short | Impact of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography on the Therapeutic Decision of Prostate Carcinoma Primary Staging: A Retrospective Analysis at the Brazilian National Public Health System |
title_sort | impact of prostate-specific membrane antigen positron emission tomography/computed tomography on the therapeutic decision of prostate carcinoma primary staging: a retrospective analysis at the brazilian national public health system |
topic | Urologic Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062252/ https://www.ncbi.nlm.nih.gov/pubmed/36995451 http://dx.doi.org/10.1245/s10434-023-13365-y |
work_keys_str_mv | AT dasilvaannacarolinaborges impactofprostatespecificmembraneantigenpositronemissiontomographycomputedtomographyonthetherapeuticdecisionofprostatecarcinomaprimarystagingaretrospectiveanalysisatthebraziliannationalpublichealthsystem AT detoledoluisgustavomorato impactofprostatespecificmembraneantigenpositronemissiontomographycomputedtomographyonthetherapeuticdecisionofprostatecarcinomaprimarystagingaretrospectiveanalysisatthebraziliannationalpublichealthsystem AT decarvalhofernandesroni impactofprostatespecificmembraneantigenpositronemissiontomographycomputedtomographyonthetherapeuticdecisionofprostatecarcinomaprimarystagingaretrospectiveanalysisatthebraziliannationalpublichealthsystem AT ziroldoalanrechamberg impactofprostatespecificmembraneantigenpositronemissiontomographycomputedtomographyonthetherapeuticdecisionofprostatecarcinomaprimarystagingaretrospectiveanalysisatthebraziliannationalpublichealthsystem AT sawczynguilhermevinicius impactofprostatespecificmembraneantigenpositronemissiontomographycomputedtomographyonthetherapeuticdecisionofprostatecarcinomaprimarystagingaretrospectiveanalysisatthebraziliannationalpublichealthsystem AT alarconshirlenetettmann impactofprostatespecificmembraneantigenpositronemissiontomographycomputedtomographyonthetherapeuticdecisionofprostatecarcinomaprimarystagingaretrospectiveanalysisatthebraziliannationalpublichealthsystem AT lewinfabio impactofprostatespecificmembraneantigenpositronemissiontomographycomputedtomographyonthetherapeuticdecisionofprostatecarcinomaprimarystagingaretrospectiveanalysisatthebraziliannationalpublichealthsystem |